Akers Biosciences

YTD

ALL

Why Robinhood?

You can watch AKER and buy or sell other stocks, ETFs, and their options commission-free!

About AKER

MyMD Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company, which engages in the development of drug products targeting aging, age-related, and autoimmune diseases, chronic pain, anxiety, and sleep disorders. It focuses on developing and commercializing the MyMD-1 and SUPERA-CBD therapeutic platforms.

CEO

Christopher C. Chapman, Jr., MD

CEOChristopher C. Chapman, Jr., MD

Employees

—

Employees—

Headquarters

Baltimore, Maryland

HeadquartersBaltimore, Maryland

Founded

1989

Founded1989

Employees

—

Employees—

AKER Key Statistics

Market cap

97.49M

Market cap97.49M

Price-Earnings ratio

-6.65

Price-Earnings ratio-6.65

Dividend yield

—

Dividend yield—

Average volume

557.91K

Average volume557.91K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$6.15

52 Week high$6.15

52 Week low

$0.90

52 Week low$0.90